Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund I Inc
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£65.67/£65.67
£0.56 (+0.86%)
Fund Code
POHOI
B3NLDF6
IE00B3NLDF60
Prices updated as at 10 Mar 2026
Prices in GBP
Investment objective
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies. The Fund will at all times invest at least two thirds of its total assets (excluding cash) in healthcare-related companies worldwide. The Fund will invest at least 51% of its gross assets on a continuous basis directly in Equity Participations. Subject to the investment restrictions described in Appendix II of the Prospectus, investments will be made in transferable securities including, but not limited to, shares, equity warrants and other types of securities such as preferred shares, which may be listed on a Regulated Market or unlisted, and issued by companies, and Global, American and European depository receipts. The Fund may not invest more than 10% of its Net Asset Value in unlisted securities.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Portfolio as of 31/01/2026
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Large core
24.39%
% Weight
Value
Core
Growth
Large
5
24
17
Medium
3
0
15
Small
2
12
22
Valuation
Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund I Inc
Sector Equity Healthcare
21.04
1.36
3.98
9.89
Growth rate
Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund I Inc
Sector Equity Healthcare
8.54%
0.74%
10.31%
Top 10 holdings
1
Eli Lilly and Co
Sector
-
Country
United States
% of assets
9.26432
2
argenx SE
Sector
-
Country
United States
% of assets
6.37858
3
Teva Pharmaceutical Industries Ltd ADR
Sector
-
Country
Israel
% of assets
5.90563
4
Roche Holding AG
Sector
-
Country
Switzerland
% of assets
5.6855
5
Chugai Pharmaceutical Co Ltd
Sector
-
Country
Japan
% of assets
5.23913
6
Novo Nordisk AS Class B
Sector
-
Country
Denmark
% of assets
4.59598
7
Fresenius SE & Co KGaA
Sector
-
Country
Germany
% of assets
4.46314
8
Torrent Pharmaceuticals Ltd
Sector
-
Country
India
% of assets
4.1377
9
Zealand Pharma AS
Sector
-
Country
Denmark
% of assets
3.89742
10
Enliven Therapeutics Inc
Sector
-
Country
United States
% of assets
3.3165
Assets in top 10 holdings %
52.88%
Total no. of equity holdings
33.00
Total no. of bond holdings
-
Stock sectors
Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund I Inc
Sector Equity Healthcare
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
100.00%
Con defensive
Healthcare
Utilities